Dose Optimization for Rubidium PET Imaging in Patients With Known or Suspected Ischemic Heart Disease
Dose Optimization for Rubidium PET Imaging in Patients With Known or Suspected Ischemic Heart Disease
Active, not recruiting · NCT05037799 · Registry updated 2026-05-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Optimization for Rubidium PET Imaging in Patients With Known or Suspected Ischemic Heart Disease | cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not stated | 2026-05-12 | NCT05037799 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jubilant DraxImage Inc. | 2 |
| Ottawa Heart Institute Research Corporation | 64 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Ottawa Heart Institute | Ottawa | Canada | 61 |